JP7805602B2 - Product provision system - Google Patents

Description

The present invention relates to a product provision system and method in which a product is selected using a user's terminal device and the product is provided via a product provision processing device.

In recent years, vending machines have begun to offer a wider variety of products, improving user convenience.

In addition, depending on the product stored in the vending machine (e.g., medicine, alcohol, tobacco, etc.), the product cannot be dispensed to the user unless the user receives approval and confirmation from a sales manager or other person.

For example, when providing pharmaceutical products from a vending machine, a sales system and method are known in which a pre-installed vending machine (medicine supply device, vending machine) is used to conduct a medical interview with a pharmacist via a video conferencing system or the like, and once the patient decides to purchase the pharmaceutical recommended by the pharmacist during the interview, the pharmaceutical is provided from the vending machine in response to the pharmacist's operation and instructions (see, for example, Patent Documents 1 and 2).

JP 2013-109414 A JP 2003-114932 A

However, product provision processing devices (vending machines) store predetermined products, and there is a problem in that it is difficult to find a location where a product provision processing device can provide the product that the user wants to purchase.

In particular, when purchasing products using a pre-installed vending machine with the approval of a sales manager, etc., as in Patent Documents 1 and 2, if the location of the vending machine cannot be found in the first place, the product cannot be purchased. Furthermore, if the vending machine is installed in a public place, users may be reluctant to make private comments even when asked questions (such as a medical interview) by the sales manager, etc. Therefore, if users receive products from a vending machine, etc. only after receiving the approval and confirmation of a sales manager, etc., there is still room for improvement in convenience.

The present invention aims to solve the above-mentioned problems by providing a product provision system and method that improves the convenience of product provision when receiving products from a product provision processing device.

In order to solve the above problems, the present invention provides a product provision system in which a user terminal device operated by a user, a product provision processing device for providing products , and a manager terminal device operated by a manager for providing the products are communicably connected to a server,
a product selection means for selecting a product by operating the user terminal device; a specific product determination means for determining whether the product selected by the product selection means is a specific product; a product registration means for registering the product selected by the product selection means; a location information extraction means for extracting location information of a location where the product provision processing device capable of providing the product registered by the product registration means is installed; a location information transmission means for transmitting the location information extracted by the location information extraction means to the user terminal device; a product provision means for providing the product registered by the product registration means to the user; and a person in charge approval means for allowing the person in charge to approve the product to be provided to the user by the person in charge terminal device ,
when the specific product determination means determines that the product is not a specific product, the product registration means registers the product selected by the product selection means without requiring approval for provision of the product from the responsible person by the responsible person approval means ,
When the specific product determination means determines that the product is a specific product, and the selection of the product is approved by the responsible person approval means, the product selected by the product selection means is registered .

Preferably, the product provision system according to the present invention further comprises a warning product determination means for determining whether or not a product selected by the product selection means is a warning product from the viewpoint of preventing health damage, even if the product is not the specific product,
It is desirable that the product providing means, when it is determined by the warning product determination means that the product is not a warning product before providing it, provides the user with the product registered by the product registration means, and when it is determined by the warning product determination means that the product is a warning product before providing it, provides the user with the product registered by the product registration means on the condition that the product has been approved by the responsible person approval means.

This invention improves the convenience of purchasing products when receiving products from a product provision processing device.

1 is an example of a perspective view of the product providing processing apparatus according to the first embodiment of the present invention when the door is closed. FIG. 1 is an example of a perspective view of the product providing processing apparatus according to the first embodiment when the door is open. FIG. 1 is a schematic diagram illustrating an example of a side view of a product providing processing device according to a first embodiment; 1 is a block diagram illustrating an example of a configuration of a product providing system according to a first embodiment. 10 is a sequence diagram illustrating an example of a process transition when a reservation is accepted in the product providing system according to the first embodiment. 10 is a sequence diagram illustrating an example of a process transition when a reservation is received in the product provision system according to the first embodiment. 10 is an example of a flowchart showing a main control process of the product provision processing device according to the first embodiment. 10 is an example of a flowchart illustrating a product replenishment confirmation process of the product provision processing device according to the first embodiment. 10 is an example of a flowchart showing a process for preventing health damage caused by OTC medicines performed by the product provision processing device according to the first embodiment. 10 is an example of a flowchart showing a product provision process of the product provision processing device according to the first embodiment. 10 is an example of a display screen displayed on a terminal display unit of a user terminal device according to the first embodiment. 1 is an example of a display screen 1 displayed on a display unit when a reserved product is received in the product provision processing device according to the first embodiment. 10 is an example of a display screen 2 displayed on a display unit when a reserved product is received in the product provision processing device according to the first embodiment. 10 is an example of a display screen displayed on a display unit when a replenishment operation is performed in the product providing processing device according to the first embodiment. 10 is a sequence diagram illustrating an example of a process transition when a reservation is accepted in the product providing system according to the second embodiment. 10 is a sequence diagram illustrating an example of a process transition when a product is received in a reservation in the product providing system according to the second embodiment.

Embodiments of the present invention will be described in detail below with reference to the drawings. The embodiments described below are merely examples of the present invention and are not intended to limit the scope of the present invention. Furthermore, not all of the configurations and operations described in each embodiment are necessarily essential to the configurations and operations of the present invention.

In this embodiment, the direction facing the user when the user operates the product processing device is referred to as the "front," and the direction opposite the front is referred to as the "rear." Also, in this embodiment, the vertical direction/height direction of the product processing device is referred to as the "up-down direction," and the horizontal direction/width direction of the product processing device is referred to as the "left-right direction."

[Embodiment 1]
A product provision system 1 and a product provision processing device 100 according to a first embodiment of the present invention will be described. The product provision processing device 100 according to the first embodiment is a product provision processing device capable of providing pharmaceuticals as products. In particular, the product provision processing device 100 according to the first embodiment is a product provision processing device capable of providing pharmaceuticals of various sizes and capable of providing pharmaceuticals to users without subjecting them to excessive shock.

In addition, the product provision processing device 100 in embodiment 1 is of two types: a first product provision processing device 100A (a so-called vending machine) equipped with a payment unit used to pay for products, and a second product provision processing device 100B installed inside a retail store such as a convenience store and not equipped with a payment unit.
In addition, when there is no distinction between the first product provision processing device 100A and the second product provision processing device 100B, and the components and control contents common to both the first product provision processing device 100A and the second product provision processing device 100B are described, they will be referred to as product provision processing device 100.

[External configuration of product provision processing device]
First, the external configuration of the product providing processing device 100 according to embodiment 1 will be described. Fig. 1 is an example of a perspective view of the product providing processing device 100 according to embodiment 1 when the door 3 is closed, and Fig. 2 is an example of a perspective view of the product providing processing device 100 according to embodiment 1 when the door 3 is open. Also, Fig. 3 is an example of a schematic diagram showing the configuration of a side view of the product providing processing device 100 according to embodiment 1.

Figure 1(a) is an example of a perspective view of the first product providing and processing device 100A when the door 3 is closed, and Figure 1(b) is an example of a perspective view of the second product providing and processing device 100B when the door 3 is closed.

As shown in FIG. 1(a), a door 3 is provided on the front of the housing 2 of the first product provision processing device 100A. When the door 3 is opened, a replenisher can perform tasks such as replenishing medicines and collecting payment for the medicines.

On the front side of the door 3, there is a touch screen consisting of a display unit 10 that displays information such as drug descriptions and code information such as QR codes (registered trademark), and an operation input unit 11 that accepts user selection operations.

In addition, a product outlet 12 is provided on the front of the door 3, allowing users to remove purchased medicines. An open/close door 13 is pivotally supported in front of and above this product outlet 12 to prevent the entry of dust, sand, and pests.

In this embodiment, the product outlet 12 is located slightly in the center of the door 3. This allows the user to take out purchased medicines in a stable position without having to bend their back or knees. The product outlet 12 may also be located in the lower or upper part of the door 3.

In addition, a speaker 19 for outputting audio and other sounds and an external camera 20 for photographing the user are provided at the upper part of the front side of the door 3.

The front of the door 3 of the first product processing device 100A is provided with payment units: a coin insertion unit 14 that accepts coins, a bill validation unit 15 that accepts banknotes, and a card payment unit 16 that accepts card monetary information. Furthermore, a receipt printer 17 that prints receipts and a change outlet 18 for taking out change are also provided.

As shown in FIG. 1(b), like the first product provision processing device 100A, the second product provision processing device 100B has a door 3 on the front of the housing 2 of the second product provision processing device 100B, and the front side of the door 3 is provided with a display unit 10, an operation input unit 11, a product removal opening 12, a speaker 19, and an external camera 20. However, unlike the first product provision processing device 100A, the second product provision processing device 100B does not have a payment unit (coin insertion unit 14, bill validation unit 15, card payment unit 16, receipt printer 17, change removal opening 18). Pharmaceuticals provided by the second product provision processing device 100B are accounted for at the retailer where the second product provision processing device 100B is installed.

As shown in FIG. 2, both the first product processing device 100A and the second product processing device 100B have multiple storage sections 30 inside them that store pharmaceuticals according to type of pharmaceutical P and are partitioned by multiple storage lanes R1-R4 in the left-right direction and multiple storage levels D1-D10 in the up-down direction. In this embodiment, it is possible to provide 40 storage sections 30 partitioned by four storage lanes R1-R4 and ten storage levels D1-D10, but the number of storage lanes and storage levels can be freely modified as needed. For example, there may be six storage lanes and six storage levels.

The multiple storage units 30 are each formed with a substantially identical structure and are arranged so that their width and length directions align with the width and front-to-rear directions of the product providing and processing device 100, respectively. Furthermore, each storage unit 30 is removable from the product providing and processing device 100, and is capable of storing pharmaceuticals of various sizes according to the size of the pharmaceuticals.

For example, as shown in FIG. 2, by removing the storage section 30 separated by the third storage lane R3 and the sixth storage tier D6, tall pharmaceuticals Ph can be stored in the storage section 30 separated by the third storage lane R3 and the seventh storage tier D7. Also, like the two storage sections 30 separated by the first storage lane R1, the second storage lane R2, and the fifth storage tier D5, wide pharmaceuticals Pw can be stored across two storage sections 30. In this way, the product provision processing device 100 according to this embodiment can provide pharmaceuticals of various sizes according to the size of the pharmaceuticals.

As shown in Figure 3, each storage unit 30 is equipped with a conveyor 31 that transports the medicines P stored in the storage unit 30 forward, and a pusher 32 that pushes the medicines P placed on the conveyor 31 forward. Note that medicines P stored across multiple storage units 30 will be driven by multiple conveyors 31 simultaneously.

In addition, an elevator 40 is provided inside the product processing device 100, located between the door 3 and the multiple storage sections 30 and configured to be able to move up and down in the vertical direction of the product processing device 100. The elevator 40 receives pharmaceuticals transported from the storage sections 30 and transports the received pharmaceuticals to the product outlet 12.

As shown in Figures 2 and 3, the elevator 40 is formed in a rectangular cylindrical shape with opening edges on both ends in the front-to-rear direction of the product providing and processing device 100. More specifically, the elevator 40 is formed in a rectangular cylindrical shape and includes a tray 41 on which pharmaceuticals transported from the storage unit 30 can be placed, a flat ceiling panel 42 positioned opposite and above the tray 41, and side panels 43 located on both left-to-right ends of the tray 41 and ceiling panel 42 and connecting the tray 41 and ceiling panel 42.

The length of the tray 41 in the left-right direction is equal to or greater than the width of all storage lanes R1 to R4 in the left-right direction, allowing wide medicines Pw stored across multiple storage lanes to be placed on the tray 41. Furthermore, as shown in Figure 3, the tray 41 is gently inclined toward the front, allowing medicines transported to the tray 41 to slide down into the product outlet 12, making it easy for the user to retrieve the medicines provided from the product outlet 12.

The vertical length of the side panel 43 is approximately the same as the height H spanning two vertically adjacent storage levels, allowing tall pharmaceuticals Ph stored across two storage levels to be placed on the tray 41.

An internal camera 21 that photographs the storage unit 30 is also mounted on the ceiling board 42. As shown in FIG. 3, an opening 42a that is inclined downward toward the storage unit 30 is formed in the mounting area of the ceiling board 42 where the internal camera 21 is mounted. Through this opening 42a, the internal camera 21 can photograph the storage unit 30, which is located opposite the elevator 40, and the medicines stored in that storage unit 30.

In this embodiment, the internal camera 21 is mounted on the ceiling board 42, but the location of the internal camera 21 is not limited to the ceiling board 42 as long as the internal camera 21 can capture images of the medicines stored in the storage unit 30.

Furthermore, inside the product processing device 100, a barrier shelf 50 is provided, which faces the product outlet 12, is located behind the elevator 40, is positioned above and below the storage section 30, and is formed in an approximately L-shape when viewed from the side of the product processing device 100.

The barrier shelf 50 has a flat barrier portion 51 that is parallel to the vertical direction of the product processing device 100, and a flat shelf portion 52 that is perpendicular to the vertical direction of the product processing device 100. A control board 53 used to control the product processing device 100 is placed on the shelf portion 52.

As shown in FIG. 3, the elevator 40 waits in a waiting position between the product outlet 12 and the barrier shelf 50 before dispensing the medicine.

When the elevator 40 is waiting in the standby position, the barrier 51 is configured to block the rear opening edge of the elevator 40 so that at least products cannot pass through the gap between the rear opening edge of the elevator 40 and the barrier 51. As a result, even if someone tries to reach into the product outlet 12 of the product providing and processing device 100 and illegally remove products while the elevator 40 is waiting in the standby position, the elevator 40 is formed in a rectangular tube shape, with the tray 41 and ceiling panel 42 acting as walls in the vertical direction, the side panels 43 acting as walls in the horizontal direction, and the barrier 51 acting as a wall in the rear direction, preventing the illegal removal of products.

In addition, by placing the control board 53 on the shelf portion 52 of the barrier shelf 50, the limited installation space inside the product processing device 100 can be effectively utilized. In addition, because the barrier shelf 50 is located approximately in the center of the product processing device 100 in the vertical direction, the control board 53 can be protected even if the product processing device 100 becomes flooded.

Furthermore, with regard to the operation of the elevator 40, the waiting position of the elevator 40 is located slightly toward the center (approximately the center position) of the storage levels D1 to D10 in the vertical direction, which shortens the lift distance from the waiting position to the storage level D of the storage unit 30 where the medicines to be provided are stored, thereby also improving the speed at which the medicines are provided.

As shown in Figures 2 and 3, a shutter mechanism 90 is provided on the back of the door 3 above the product outlet 12 to open and close the opening and closing door 13 pivotally supported by the product outlet 12.

Also, as shown in Figures 2 and 3, in the first product provision processing device 100A, a monetary information input/output unit 60 is provided on the back of the door 3. The monetary information input/output unit 60 is connected to the coin insertion unit 14, bill validation unit 15, card payment unit 16, receipt printer 17, and change outlet 18, and inputs and outputs monetary information, card information, and change information.

Note that the second product provision processing device 100B, unlike the first product provision processing device 100A, does not have a payment unit and therefore does not have a monetary information input/output unit 60.

[Internal configuration of product provision system]
Next, a description will be given of the internal configuration of a product provision system in which a user selects a medicine using the terminal device 200 and the medicine is provided via the product provision processing device 100. Fig. 4 is an example of a block diagram showing the configuration of the product provision system 1 according to the first embodiment.

As shown in FIG. 4, the product provision system 1 according to embodiment 1 is composed of multiple product provision processing devices 100 (first product provision processing device 100A and second product provision processing device 100B), a user terminal device 200 operated by a user, a server 300 that performs various processes, and multiple pharmacist terminal devices 340 operated by pharmacists who are responsible for providing pharmaceuticals. The server 300 connects the product provision processing devices 100, user terminal devices 200, and pharmacist terminal devices 340 so that they can communicate with each other via public lines.

The first product provision processing device 100A includes at least a display unit 10, an operation input unit 11, a speaker 19, an external camera 20, an internal camera 21, a conveyor 31, an elevator 40, a monetary information input/output unit 60, a control unit 70, a communication unit 80, a memory unit 81, and a shutter mechanism 90. In this embodiment, the control unit 70, the communication unit 80, and the memory unit 81 are mounted on a control board 53 (see Figure 3).

The conveyor 31 is equipped with a belt drive unit 34 consisting of a motor that drives the belt on which the medicines are placed, and a belt position sensor 35 that detects the position of the belt.

The elevator 40 is equipped with an elevator drive unit 44 consisting of a motor that raises and lowers the elevator 40 in the vertical direction, and an elevator sensor 45 that detects the position of the elevator 40.

The shutter mechanism 90 includes an opening/closing drive unit 91 consisting of a motor that opens and closes the opening/closing door 13, which is pivotally supported on the product outlet 12, and a shutter sensor 92 for detecting the open/closed state of the opening/closing door 13.

The control unit 70 consists of a processor such as a CPU (Central Processing Unit) and executes a predetermined control program stored in the memory unit 81 to perform various controls for providing pharmaceuticals.

The control unit 70 is connected to the operation input unit 11, belt position sensor 35, and elevator sensor 45 via an input port (not shown) on the control board 53, and is configured to allow various information to be input to the control unit 70 from these devices. The control unit 70 is also connected to the display unit 10, belt drive unit 34, and lift drive unit 44 via an output port (not shown) on the control board 53, and is configured to allow various information to be output from the control unit 70 to these devices. The control unit 70 is also connected to the external camera 20, internal camera 21, monetary information input/output unit 60, and communication unit 80 via an input/output port (not shown) on the control board 53, and is configured to allow various information to be input and output between the control unit 70 and these devices.

The communication unit 80 consists of a communication module that establishes a communication state between the first product provision processing device 100A and the server 300 (the product provision server 310 described below) to enable mutual communication, and the communication method can be either wired or wireless.

The memory unit 81 is a non-volatile memory storage device that stores control programs and temporary information used by the control unit 70 to perform various controls.

Like the first product provision processing device 100A, the second product provision processing device 100B also has a display unit 10, an operation input unit 11, a speaker 19, an external camera 20, an internal camera 21, a conveyor 31 (belt drive unit 34, belt position sensor 35), an elevator 40 (lift drive unit 44, elevator sensor 45), a control unit 70, a communication unit 80, and a memory unit 81. However, unlike the first product provision processing device 100A, the second product provision processing device 100B does not have a payment unit and therefore does not have a monetary information input/output unit 60.

The user terminal device 200 is a terminal device such as a personal computer, tablet, or smartphone, and is operated by a user. The user terminal device 200 includes at least a terminal control unit 201, a terminal memory unit 202, a terminal input unit 203, a terminal display unit 204, and a code reading unit 205.

The terminal control unit 201 is composed of a processor such as a CPU, and performs various controls in response to user operations. In particular, the terminal control unit 201 accesses the server 300 (the product provision server 310, described below) and controls the product provision server 310 to select pharmaceuticals.

The terminal memory unit 202 consists of readable and writable non-volatile flash memory, and stores various information received from the product provision server 310.

The terminal input unit 203 consists of an input unit such as a keyboard or touch panel, and allows information related to user operations to be input.

The terminal display unit 204 consists of an image display device that displays images, such as an LCD display or an organic EL display, and is capable of displaying images in response to user operations or images received from the product providing server 310.

The code reading unit 205 is a code reader that can read code information displayed on the display unit 10 of the product provision processing device 100 and analyze the read code information.

The server 300 consists of a product provider server 310, a pharmacist server 320, and a database storage unit 330.

The product provision server 310 is a server that performs processing to provide pharmaceuticals, and is connected to the product provision processing device 100, the user terminal device 200, the pharmacist server 320, and the database storage unit 330. The product provision server 310 selects pharmaceuticals based on operational instructions from the user terminal device 200, and transmits map information on the location of the product provision processing device 100 to the user terminal device 200. The product provision server 310 also authorizes the product provision processing device 100 to provide pharmaceuticals. The product provision server 310 also instructs the pharmacist server 320 to have a pharmacist approve the request.

The pharmacist server 320 is a server that performs processing related to the pharmacist terminal device 340, and is connected to the product provider server 310, the database storage unit 330, and the pharmacist terminal device 340. The pharmacist server 320 keeps track of the number of accesses to the pharmacist terminal device 340, allows the pharmacist to approve the request, and pays incentives to the pharmacist terminal device 340.

The database storage unit 330 is composed of a large-capacity storage device such as a hard disk drive (HDD), solid state drive (SDD), optical disk drive, or magnetic tape device, and stores various information for providing pharmaceuticals. Specifically, the database storage unit 330 stores various information for providing pharmaceuticals, such as "pharmaceutical information," "reserved product information," "provided product information," and "user image" associated with user-specific information, location information associated with product provision processing device-specific information, product inventory, storage unit provision status (storage unit provision permitted state, storage unit provision suspended state), sample replenishment product image information, and pharmacist-specific information.

In this embodiment, "drug information" includes the classification of various drugs (class 1, class 2, or class 3 drugs), information on ingredients contained in various drugs, contraindicated combinations of various ingredient information that result in contraindications for combined use, cautionary combinations of various ingredient information that result in cautions for combined use, sample product images of various drugs, etc. Furthermore, "reserved product information" includes the reserved drug, the number reserved, the time the reservation was completed, and unique information about the pharmacist who interviewed the patient. Furthermore, "provided product information" includes the provided drug, the number provided, the time of provision, and unique information about the product provision processing device that provided the drug.

In this embodiment, the product provider server 310 and the pharmacist server 320 are configured separately, but the product provider server 310 may have the functions of the pharmacist server 320 and may be configured as a single server. Furthermore, the servers may be divided into more detailed functional groups, and configured as three or more servers.

The pharmacist terminal device 340 is a terminal device such as a PC, tablet, or smartphone, and is operated by a pharmacist.

The pharmacist terminal device 340 also has an identity authentication function that uses biometric authentication, such as a camera, to verify whether the pharmacist is a pre-registered pharmacist. This identity authentication function authenticates the pharmacist each time they log in to the pharmacist terminal device 340, perform various approval tasks, etc. This makes it possible to prevent approval actions by anyone other than a qualified pharmacist.

[Product provision system sequence diagram]
Next, a description will be given of the process transition of the product provision system 1. Fig. 5 is an example of a sequence diagram showing the process transition when a reservation is accepted by the product provision system according to the first embodiment, and Fig. 6 is an example of a sequence diagram showing the process transition when a reservation is received by the product provision system according to the first embodiment.

The sequence diagrams shown in Figures 5 and 6 show, from left to right, the processing of the user terminal device 200, product provision processing device 100, server 300 (product provision server 310 and pharmacist server 320), and pharmacist terminal device 340. Note that for each process described below, the elements of step S are shown in an exemplary order and are not limited to the specific order shown. Therefore, in the flowcharts shown in Figures 5 and 6, the order can be changed as long as no inconsistencies arise in the processing results. The same applies to Figures 7 to 10, 15, and 16, which will be described later.

(Sequence when accepting reservations)
A case where the user decides to reserve a medicine through the user terminal device 200 will be described.

As shown in FIG. 5, when a user logs in to the product providing server 310, the user terminal device 200 performs a product selection login process (step S1).
In this product selection login process, first, the user's unique information such as a password is transmitted to the product providing server 310 .

When the product providing server 310 receives the user's unique information from the user terminal device 200, the product providing server 310 performs a user authentication process (step S31).
In this user authentication process, it is determined whether the user's unique information received from the user terminal device 200 is unique to a user registered in the database storage unit 330. Then, user authentication result information indicating whether the received user's unique information is unique to a registered user is sent to the user terminal device 200. Furthermore, if the received user's unique information is unique to a previously registered user, the user authentication is deemed successful, the received user's unique information is registered as unique information of the accessing user, and a communication state between the product providing server 310 and the user terminal device 200 is established.

When the user terminal device 200 receives the user authentication result information indicating that the user authentication has been successful, the user terminal device 200 performs a reserved product determination process to determine the medicine provided by the product provision processing device 100 as the reserved product (step S2).
In this reservation product determination process, a medicine is selected based on the name of the medicine or the symptoms, and the medicine to be provided by the product provision processing device 100 is determined as a reserved product.

After the reserved product is determined, the user terminal device 200 performs a specific reserved product determination process to determine whether the reserved product is a specific medicine (step S3).
In this specific reserved product determination process, it is determined whether the reserved product is a specific drug (e.g., a first-class drug). If it is determined that the reserved product is a specific drug, the process proceeds to the medical interview request process in step S4. If it is determined that the reserved product is not a specific drug but a regular drug (e.g., an OTC drug such as a second-class or third-class drug), the process proceeds to the regular reserved product confirmation process in step S6 without performing the processes in steps S4 and S5.

In addition, if the user terminal device 200 determines that the medicine decided as the reserved product is a specific medicine, it performs an interview request process to have the user interview a pharmacist about the specific medicine (step S4).
In this medical interview request process, reservation product information of the specific medicine determined as the reserved product, medical interview request information requesting a medical interview from a pharmacist, and the like are transmitted to the product providing server 310 .

When the product provider server 310 receives reservation product information, medical interview request information, etc., it transfers the reservation product information, medical interview request information, etc. to the pharmacist server 320.

When the pharmacist server 320 receives the reserved product information, medical interview request information, etc. via the product provider server 310, it performs a medical interview reception start process to receive a medical interview from the pharmacist (step S32).
In this medical interview reception start process, medical interview reception information notifying that a medical interview for the user is scheduled is transmitted to all pharmacist terminal devices 340 .

When the pharmacist terminal device 340 receives medical interview reception information from the pharmacist server 320, it is notified that a medical interview is available for the user.

When a pharmacist wishes to ask a question about a user, the pharmacist terminal device 340 first performs a pharmacist login process to log in to the pharmacist server 320 (step S51).
In this pharmacist login process, the pharmacist's identity is first authenticated using biometric authentication such as a camera mounted on the pharmacist terminal device 340, and if the authentication is successful, the pharmacist's unique information is sent to the pharmacist server 320.

When the pharmacist server 320 receives the pharmacist's unique information from the pharmacist terminal device 340, it performs a pharmacist authentication process to authenticate the received pharmacist's unique information (step S33).
In this pharmacist authentication process, it is determined whether the received pharmacist's unique information is the unique information of a pharmacist registered in the database storage unit 330, and if the received pharmacist's unique information is the unique information of a registered pharmacist, it is determined that authentication of the pharmacist has been successful. Pharmacist authentication result information indicating the pharmacist authentication result is then sent to the pharmacist terminal device 340. Furthermore, if pharmacist authentication is successful, the received pharmacist's unique information is registered as the unique information of the pharmacist currently accessing the pharmacist server 320, and the access count of the pharmacist currently accessing the pharmacist server 320 is updated.

When the pharmacist terminal device 340 receives pharmacist authentication result information from the pharmacist server 320 indicating that the pharmacist authentication was successful, it can request a user interview, as described below.

When the user requests a medical interview, the pharmacist terminal device 340 performs a medical interview request process (step S52).
In this medical interview application process, the pharmacist's identity is authenticated using biometric authentication such as a camera installed on the pharmacist terminal device 340, and if the authentication is successful, the medical interview application information and the pharmacist's unique information are sent to the pharmacist server 320.

When the pharmacist server 320 receives the medical interview application information and the pharmacist's unique information, it performs a medical interview allocation process (step S34) to determine whether or not to allow a medical interview application from any of the pharmacist terminal devices 340.
In this medical interview allocation process, the pharmacist terminal device 340 that first sent medical interview application information to the pharmacist server 320 is granted permission to request the user's medical interview (on a first-come, first-served basis), and communication is established between the pharmacist terminal device 340, the pharmacist server 320, and the user terminal device 200. This shortens the waiting time for a pharmacist to participate in the user's medical interview. In addition, medical interview application result information indicating whether the medical interview request from the pharmacist terminal device 340 was granted is sent to the pharmacist terminal device 340.

The user terminal device 200 performs an inquiry process to ask a question to the pharmacist terminal device 340 with which communication has been established (step S5).
In this medical interview process, the user answers questions about the medical interview from the pharmacist via the pharmacist terminal device 340 using text-based means such as chat or voice conversation, and the information on the answered questions is sent to the pharmacist server 320.

The pharmacist server 320 performs a medical interview content transmission process (step S35) to transmit the medical interview content from the user terminal device 200.
In this medical interview content transmission process, medical interview content information indicating the medical interview content from the user is transmitted to the pharmacist terminal device 340 that has permitted the user's request for a medical interview.

When the pharmacist operates the medical interview result based on the medical interview content from the user, the pharmacist terminal device 340 performs a pharmacist first approval process, which sends first approval result information indicating the medical interview result to the pharmacist server 320 (step S53).
In this pharmacist first approval process, when a pharmacist performs an approval operation to approve a specific medicine, the first approval information is sent to the pharmacist server 320 as first approval result information, and when a pharmacist performs a denial operation to not approve the specific medicine, the first denial information is sent to the pharmacist server 320 as first approval result information.

When the pharmacist server 320 receives the first approval result information from the pharmacist terminal device 340, it performs a first incentive payment process (step S36).
In this first incentive payment process, the unit price of the incentive is first set based on the current number of accesses by the pharmacist. Then, a payment process is performed in which the first incentive, which is a portion (e.g., 50%) of the set incentive unit price, is paid to the pharmacist who approved the specific drug by transmitting the first incentive as electronic money to the pharmacist terminal device 340 or transferring it to the pharmacist's bank account. Furthermore, the pharmacist server 320 transfers the first approval result information received from the pharmacist terminal device 340 to the product provider server 310.

Here, it is desirable to set the incentive unit price higher during times when pharmacist access is low, such as late at night or on holidays, and lower during times when pharmacist access is high, such as during the day or on weekdays. This makes it possible to automatically control the setting of the incentive unit price during times when access is low, and ensures that approval work by pharmacists can be carried out stably during times such as late at night or on holidays.

In addition, a portion of the incentive will be paid to the pharmacist who first sends the medical interview application information to the pharmacist server 320 and approves the specific drug.

When the product provider server 310 receives the first approval result information from the pharmacist terminal device 340 via the pharmacist server 320, the product provider server 310 performs a specific reserved product confirmation process (step S37).
In this specific pre-order product confirmation process, when first approval information is received as first approval result information, the specific medicine determined as the pre-order product is confirmed, and when first denial information is received as first approval result information, the information on the specific medicine determined as the pre-order product is discarded.

If the user terminal device 200 determines that the medicine determined as the reserved product is a normal medicine and not a specific medicine, it performs a normal reserved product confirmation process to confirm the normal medicine determined as the reserved product (step S6). Note that if the medicine determined as the reserved product is determined to be a specific medicine, the normal reserved product confirmation process is not performed.
In this reservation result process, information about the reserved product determined as the reserved product, user specific information, etc. are transmitted to the product providing server 310 .

The product providing server 310 performs a reserved product registration process to register information about the confirmed reserved product in the database storage unit 330 (step S38).
In this reserved product registration process, the registration information of the reserved product (reserved medicine, number of reserved items, reservation completion date, and unique information of the pharmacist who interviewed the patient) is registered in the database storage unit 330 in association with the unique information of the user.

After performing the reserved product registration process, the product providing server 310 performs a location information extraction process to extract location information of the product providing processing device 100 that can provide the reserved product (step S39).
In this location information extraction process, information about the product provision processing devices 100 stored in the database storage unit 330 is referenced, and unique information about product provision processing devices that have a quantity of the product corresponding to the reserved product in stock and whose storage unit 30 storing the product corresponding to the reserved product is in a storage unit provision permitted state is extracted. Then, location information associated with the extracted unique information about the product provision processing device is extracted, and the extracted location information is transmitted to the user terminal device 200. In this way, by extracting location information about product provision processing devices 100 that have a quantity of the product in stock and are in a storage unit provision permitted state, it is possible to reduce the chance of being unable to receive the reserved medicine because the product provision processing device 100 is sold out or in a suspended state when receiving the reserved medicine. Furthermore, in the location information extraction process, registration information for the reserved product registered in the reserved product registration process is transmitted to the user terminal device 200.

When the user terminal device 200 receives the registration information of the reserved item and the location information of the product provision processing device 100 from the product provision server 310, it performs a reservation result list display process that displays the registration information of the reserved item and the location information of the product provision processing device 100 (step S7).
In this reservation result list display process, first, the received registration information of the reserved item is stored in the terminal storage unit 202. Then, based on the registration information of the reserved item and the location information of the product provision processing device 100, an explanatory image showing the registration information of the reserved item and a location information image showing the location of the product provision processing device are displayed on the terminal display unit 204. This explanatory image allows the user to confirm which medicines have been reserved, and the display of the location information image allows the user to know where to go to pick up the medicines from the product provision processing device 100.

(Sequence when receiving a reservation)
Next, a case where the user receives the reserved product from the product supply processing device 100 will be described.

As shown in FIG. 6, the product provision processing device 100 performs a reception standby process for receiving an operation from a user or the like (step S11).
In this reception waiting process, the type of operation from the user is determined, and if the user performs an operation to receive the reserved item, the process proceeds to an authentication code information display process (step S12).

When the user performs an operation to receive the reserved product, the product provision processing device 100 performs an authentication code information display process (step S12).
In this authentication code information display process, authentication code information is displayed on the display unit 10 of the product provision processing device 100. This "authentication code information" includes reservation connection information (URL) for connecting to the product provision server 310, unique information of the product provision processing device, reservation product call instruction information for calling up registration information of the reservation product stored in the terminal storage unit 202 of the user terminal device 200, etc.

When the authentication code information is displayed on the display unit 10 of the product provision processing device 100, the user terminal device 200 performs an authentication code information reading process (step S8).
In this authentication code information reading process, the authentication code information displayed on the display unit 10 of the product provision processing device 100 is read, the read authentication code information is analyzed, and the analyzed authentication code analysis information (reservation connection information, product provision processing device specific information, reserved product call instruction information, etc.) is obtained. Then, based on the reserved product call instruction information included in the authentication code analysis information, the registration information of the reserved product stored in the terminal storage unit 202 is called up.

After acquiring the authentication code analysis information, the user terminal device 200 performs a reservation registration information transmission process (step S9).
In this reservation registration information transmission process, the product provision server 310 is accessed based on the reservation connection information contained in the authentication code analysis information, and the registration information of the called-up reserved product, the user's unique information, the unique information of the product provision processing device contained in the authentication code analysis information, etc. are transmitted to the product provision server 310.

When the product providing server 310 receives the registration information of the reserved product, the user's unique information, the product providing processing device's unique information, and the like from the user terminal device 200, it performs a destination allocation process (step S41).
In this destination allocation process, the registration information of the reserved product, the user's unique information, etc. are transmitted to the product provision processing device 100 having the unique information of the received product provision processing device.

When the product provision processing device 100 receives the registration information of the reserved product, the user's unique information, and the like from the product provision server 310, the product provision processing device 100 performs a product grade determination process (step S13).
In this product grade determination process, it is determined whether the reserved medicine is a "medicine requiring caution" based on the registered information of the reserved product.

The term "drugs requiring caution" is not limited to the specific drugs mentioned above (for example, Category 1 OTC drugs), but also includes OTC drugs that may cause health damage if the ingredients contained in them are abused in excess of the appropriate dosage, and drugs that may cause health damage when the ingredients contained in them are combined with the ingredients of other drugs (cautionary notes for combined use/contraindications for combined use). This refers to drugs that may cause health damage in a broader sense than the specific drugs mentioned above.

If the product provision processing device 100 determines in the product grade determination process that the reserved drug is a drug requiring caution, it proceeds to the OTC drug eligibility determination process in step S14.If it determines that the reserved drug is not a drug requiring caution, it skips steps S14 to S16 and proceeds to the provided product confirmation process in step S18.

When the product provision processing device 100 determines that the reserved medicine is a medicine requiring caution, it performs a process of determining whether the medicine is an OTC medicine (step S14).
In this OTC drug eligibility determination process, it is determined whether the OTC drug is a drug for which health hazards should be suppressed. If it is determined that the OTC drug is a drug for which health hazards should be suppressed, the process proceeds to OTC drug health hazard prevention process in step S15, and if it is determined that the OTC drug is not a drug for which health hazards should be suppressed, the process proceeds to user photography process in step S16.

When the product provision processing device 100 determines that the OTC drug is a drug for which health hazard prevention is required, the product provision processing device 100 performs a health hazard prevention process for the OTC drug (step S15).
This OTC drug health hazard prevention process includes an abuse prevention determination process that determines whether or not a predetermined number of drugs containing the ingredient information of the drug to be provided have been provided within a predetermined period, and a contraindication prevention determination process that determines whether or not the ingredient information of the drug to be provided and past ingredient information constitute a contraindicated combination or a combination with caution. Details of this OTC drug health hazard prevention process will be described later using Figure 9.

If the product provision processing device 100 determines that the reserved medicine is a medicine that requires caution, it performs a user photographing process to photograph the user using the external camera 20 (step S16).

When the user is photographed by the external camera 20, the product provision processing device 100 performs a provision application process (step S17).
In this supply application process, supply application information for requesting approval to supply medicines from a pharmacist, a user image captured by the external camera 20, user specific information, etc. are transmitted to the product supply server 310.

When the product provision server 310 receives the provision application information, user image, user's unique information, etc., it extracts the registration information for the reserved product associated with the user's unique information, and transmits the extracted registration information for the reserved product, along with the provision application information, reserved product registration information, user image, user's unique information, etc. received from the product provision processing device 100, to the pharmacist server 320.

When the pharmacist server 320 receives the registration information of the reserved product, the supply application information, the user image, the user's unique information, etc. via the product supply server 310, it performs a supply approval acceptance process (step S42).
In this provision approval acceptance process, if the drug included in the registration information for the reserved product is a specific drug, the unique information of the pharmacist who conducted the interview, included in the registration information for the reserved product, is extracted, and provision approval acceptance information notifying the approval work regarding the provision of the drug is transmitted to the pharmacist terminal device 340 having the unique information of the pharmacist who conducted the interview. In addition, in the provision approval acceptance process, if the drug included in the registration information for the reserved product is not a specific drug (if it is a regular drug that requires caution), provision approval acceptance information is transmitted to all pharmacist terminal devices 340.

When the pharmacist terminal device 340 receives the provision approval acceptance information from the pharmacist server 320, it is notified that approval work is required regarding the provision of the medicine.

When a pharmacist wishes to perform approval work regarding the provision of a pharmaceutical product, the pharmacist terminal device 340 performs the above-mentioned pharmacist login process (step S51), and the pharmacist server 320 performs the above-mentioned pharmacist authentication process (step S33). Furthermore, when the pharmacist terminal device 340 receives pharmacist authentication result information from the pharmacist server 320 indicating that the pharmacist authentication was successful, the pharmacist terminal device 340 can apply for approval work regarding the provision of a pharmaceutical product.

When applying for approval of the provision of medicines, the pharmacist terminal device 340 performs provision approval application processing (step S54).
In this provision approval application process, the pharmacist's identity is authenticated using biometric authentication such as a camera installed on the pharmacist terminal device 340, and if the authentication is successful, the provision approval application information and the pharmacist's unique information are sent to the pharmacist server 320.

When the pharmacist server 320 receives the provision approval application information and the pharmacist's unique information, it performs a provision approval allocation process (step S44) to determine whether or not to approve the approval work application from any of the pharmacist terminal devices 340.
In this supply approval allocation process, if the drug included in the registration information for the reserved product is a specific drug, an approval application is permitted for the pharmacist terminal device 340 whose received unique information for the pharmacist corresponds to the unique information for the interviewed pharmacist included in the registration information for the reserved product. Also, in the supply approval allocation process, if the drug included in the registration information for the reserved product is a regular drug that requires caution, an approval application is permitted for the pharmacist terminal device 340 that initially transmitted the supply approval application information to the pharmacist server 320. Then, supply approval application result information indicating whether the application for approval has been permitted from the pharmacist terminal device 340 is transmitted to the pharmacist terminal device 340, and the registration information for the reserved product, the user image, unique information of the user, etc. are transmitted to the pharmacist terminal device 340 that permitted the application for approval.

The pharmacist terminal device 340 receives the registration information for the reserved product, the user image, the user's unique information, etc., allowing the pharmacist to check the registration information for the reserved product, the user image, etc., and perform approval work regarding the provision of the medicine.

When the pharmacist performs the approval operation regarding the provision of the medicine, the pharmacist terminal device 340 performs a second pharmacist approval process in which second approval result information indicating the approval result is sent to the pharmacist server 320 (step S55).
In this pharmacist second approval process, when an approval operation to approve the provision of the medicine is performed, second approval information is sent to the pharmacist server 320 as second approval result information, and when a denial operation to deny the provision of the medicine is performed, second denial information is sent to the pharmacist server 320 as second approval result information. Then, upon receiving the second approval result information, the pharmacist server 320 transfers the second approval result information to the product provider server 310.

In this embodiment, the second pharmacist approval process is performed even when the drug included in the registration information for the reserved product is a regular drug (OTC drug) that requires caution. However, the second pharmacist approval process may be performed only when the drug included in the registration information for the reserved product is a specific drug (for example, a Category 1 drug). In this configuration, when the drug included in the registration information for the reserved product is a regular drug, the processes of steps S17, S42, etc. described above do not need to be performed.

When the product provider server 310 receives the second approval result information from the pharmacist terminal device 340 via the pharmacist server 320, the product provider server 310 performs a provision approval result reflection process (step S45).
In this provision approval result reflection process, second approval result information is sent to the product provision processing device 100 .

If the reserved medicine is a medicine that does not require caution, or if the reserved medicine is a medicine that requires caution and the product provision processing device 100 receives second approval result information from the product provision server 310, it performs a provided product confirmation process (step S18).
In this provided product confirmation process, if the reserved medicine is a medicine that does not require any precautions, the medicine included in the registration information of the reserved product is confirmed as the medicine to be provided.
In addition, in the process of determining the product to be provided, if the reserved medicine is a medicine requiring caution, when second approval information indicating the pharmacist's approval is received as the second approval result information, the medicine included in the registration information of the reserved product is determined to be the medicine to be provided, and when second denial information indicating the pharmacist's denial is received as the second approval result information, the medicine to be provided is not determined, and provision prohibition information is set to prohibit the provision of the reserved product.

Once the product provision processing device 100 has confirmed the medicine to be provided, it performs product provision processing to provide the confirmed medicine to the user (step S19). Then, once the product provision processing has completed providing the medicine to the user, it transmits provision completion information indicating that the provision of the reserved product has been completed, as well as the user's unique information, etc., to the product provision server 310. Details of this product provision processing will be described later using Figure 10.

When the product provision server 310 receives the provision completion information and the like from the product provision processing device 100, the product provision server 310 performs a product provision completion process (step S46).
In this product provision completion process, information about the provided products (provided medicine, number of provided medicines, time of provision, and information unique to the product provision processing device that provided the medicine) is associated with the user's unique information and registered in the database storage unit 330. Furthermore, the product provision server 310 transfers the provision completion information and the like to the pharmacist server 320.

When the pharmacist server 320 receives the provision completion information and the like from the product provision server 310, it performs a second incentive payment process (step S47).
In this second incentive payment process, if the drug is a specific drug, a payment process is performed in which the second incentive, which is the remainder (e.g., 50%) of the incentive unit price set in the first incentive payment process in step S36, is paid to the pharmacist who performed the approval work for the provision of the drug by transmitting the second incentive as electronic money to the pharmacist terminal device 340 or transferring the money to the pharmacist's bank account. Also, in the second incentive payment process, if the drug is a regular drug (OTC drug) that requires caution, a payment process is performed in which a third incentive, which is lower than the second incentive for the specific drug, is paid.

In this way, when a user decides on a specific medicine as a reserved item, the pharmacist is paid a portion of the incentive at the time of approval through a medical interview after the reserved item is decided, and the remaining amount of the incentive is paid when the product is provided by the product provision processing device 100. Therefore, even if a user decides on a reserved item but cancels the reserved item and the product is not actually provided by the product provision processing device 100, part of the incentive is paid at the time of approval through a medical interview, which encourages pharmacists to proactively perform approval tasks and improves the operating rate of the product provision system 1.

When the product provision processing device 100 completes the provision of the medicine to the user through the product provision process, it performs the inventory quantity calculation process (step S20).
In this inventory calculation process, the inventory number of medicines stored in the storage unit 30 is calculated, and information on the calculated inventory number and unique information of the product provision processing device are sent to the product provision server 310.

When the product provision server 310 receives the information on the stock quantity from the product provision processing device 100, the product provision server 310 performs a stock quantity update process (step S48).
In this stock quantity update process, the stock quantity is updated in association with the received unique information of the product provision processing device, and stored in the database storage unit 330 .

Note that the processing of the user terminal device 200, product provision processing device 100, server 300 (product provision server 310 and pharmacist server 320), and pharmacist terminal device 340 in the above sequence diagram is an example of typical processing, and many other processes are also performed to fulfill various other functions.

For example, the product provision server 310 transmits sample product images of pharmaceuticals and sample replenishment product images to the product provision processing device 100 for pattern matching, as described below.

[Control process of product provision processing device]
Next, a detailed description will be given of the control process of the product provision processing device 100. Fig. 7 is an example of a flowchart showing the main control process of the product provision processing device 100 according to the first embodiment.

(Main control process of product provision processing device)
The main control process of the product provision processing device 100 shown in FIG. 7 is a process that is carried out when power is supplied to the product provision processing device 100.

As shown in FIG. 7, in step S101, the control unit 70 performs a power interruption recovery process.
In this power interruption recovery process, various information is initialized, communication is confirmed with the product providing server 310, and necessary information is obtained from the product providing server 310. In this embodiment, information on ingredients contained in various medicines, sample product images of various medicines, and sample replenished product images when the products are properly replenished in the storage unit 30 are obtained from the product providing server 310 and stored in the memory unit 81. When this process is completed, the process proceeds to step S102.

In step S102, the control unit 70 performs a reception standby process to receive operations from the user and product replenishment operations from the replenisher.
This reception standby process corresponds to the reception standby process (step S11) shown in Fig. 6, and is a process in which a reception display screen for accepting operations from the user is displayed on the display unit 10, and the process waits for the reception of an operation from the user or an operation to replenish products from the replenisher. When an operation from the user or an operation to replenish products from the replenisher is accepted, the process proceeds to step S103.

In step S103, the control unit 70 determines whether or not an operation to start replenishment of merchandise has been received from the replenisher. Examples of operations to start replenishment from the replenisher include opening the door 3, unlocking the locked state of the door 3, and inputting a replenishment start password or the like into the operation input unit 11 by the replenisher.
If the control unit 70 determines that it has received an operation to start product replenishment from the replenisher, it proceeds to step S104; if it determines that it has not received an operation to start product replenishment from the replenisher, it proceeds to step S106.

In step S104, the control unit 70 determines whether or not an operation to end product replenishment has been received from the replenisher. Examples of operations to end product replenishment from the replenisher include closing the door 3, locking the door 3, or inputting a replenishment end password or the like into the operation input unit 11 by the replenisher.
If the control unit 70 determines that it has received an operation to terminate product replenishment from the replenisher, it proceeds to step S105, and if it determines that it has not received an operation to terminate product replenishment from the replenisher, it waits until it receives an operation to terminate product replenishment from the replenisher.

In step S105, the control unit 70 performs a product replenishment confirmation process to confirm whether the replenisher has performed the replenishment work correctly. Details of this product replenishment confirmation process will be described later using Figure 8. When this process is completed, the process returns to step S102.

In step S106, the control unit 70 determines whether or not an operation to receive the reserved item has been accepted from the user.
If the control unit 70 determines that it has accepted the user's request to receive the reserved item, it transfers processing to step S107; if it determines that it has not accepted the user's request to receive the reserved item, it transfers processing to step S115.

In step S107, the control unit 70 performs an authentication code information display process to display the authentication code information.
This authentication code information display process corresponds to the authentication code information display process (step S12) shown in Fig. 6, and causes the display unit 10 of the product provision processing device 100 to display the authentication code information. When this process is completed, the process proceeds to step S108.

In step S108, the control unit 70 determines whether or not the registration information of the reserved product and the user's unique information have been received from the product providing server 310.
If the control unit 70 determines that the registration information for the reserved item and the user's unique information have been received, it proceeds to step S109; if it determines that the registration information for the reserved item and the user's unique information have not been received, it waits until the registration information for the reserved item and the user's unique information are received.

In step S109, the control unit 70 determines whether the reserved medicine is a medicine requiring caution based on the registered information of the reserved product. The process of step S109 corresponds to the product grade determination process (step S13) shown in FIG. 6.
If the control unit 70 determines that the reserved medicine is a medicine that requires caution, it transfers processing to step S110, and if it determines that the reserved medicine is not a medicine that requires caution, it transfers processing to step S117.

In step S110, the control unit 70 determines whether the OTC drug is a drug for which health hazards should be reduced. The process in step S110 corresponds to the process for determining whether the OTC drug is a drug for which health hazards should be reduced (step S14) shown in FIG. 6 .
If the control unit 70 determines that the product is a target of a drug that should prevent health damage, it proceeds to step S111, and if it determines that the product is not a target of a drug that should prevent health damage, it proceeds to step S112.

In step S111, the control unit 70 performs processing to prevent health damage caused by OTC drugs. This processing in step S111 corresponds to the processing to prevent health damage caused by OTC drugs (step S15) shown in Figure 6. Details of this processing to prevent health damage caused by OTC drugs will be described later using Figure 9. When this processing is completed, the process proceeds to step S112.

In step S112, the control unit 70 performs a user photographing process to photograph the user using the external camera 20. The process of step S112 corresponds to the user photographing process (step S16) shown in FIG.
In this user photographing process, the user is photographed by the external camera 20, and the photographed user image is acquired. When this process is completed, the process proceeds to step S113.

In step S113, the control unit 70 performs a provision request process. The process in step S113 corresponds to the provision request process (step S17) shown in FIG.
In this supply application process, supply application information, a user image, user specific information, etc. are sent to the product supply server 310. When this process is completed, the process proceeds to step S114.

In step S<b>114 , the control unit 70 determines whether or not second approval result information has been received from the product providing server 310 .
If the control unit 70 determines that the second approval result information has been received, it proceeds to step S117; if it determines that the second approval result information has not been received, it waits until the second approval result information is received.

In step S115, the control unit 70 determines whether or not a product purchase operation has been accepted from the user.
If the control unit 70 determines that a product purchase operation has been received from the user, it proceeds to step S116, and if it determines that a product purchase operation has not been received from the user, it returns to step S102.

In step S116, the control unit 70 performs a product selection process to select a medicine by selecting the medicine based on the medicine name or the symptoms in response to a product selection operation from the user. When this process is completed, the process proceeds to step S117.

In step S117, the control unit 70 performs a provided product determination process to determine the medicine to be provided. This provided product determination process also corresponds to the provided product determination process (step S18) shown in FIG. 6.
In this provided product confirmation process, when a product purchase operation is received from the user (step S115), a product confirmation process is performed to confirm the selected medicine in response to the product confirmation operation from the user.
In the provision product confirmation process, when a user's operation to receive a reserved product is accepted (step S106), if the reserved drug is a drug that does not require caution (step S109), the drug included in the registration information of the reserved product is confirmed as the drug to be provided in response to the user's operation to confirm the product. Also, when a user's operation to receive a reserved product is accepted, if the reserved drug is a drug that requires caution, if second approval information indicating the pharmacist's approval is received as the second approval result information, the drug included in the registration information of the reserved product is confirmed as the drug to be provided in response to the user's operation to confirm the product. If second denial information indicating the pharmacist's denial is received as the second approval result information, the drug to be provided is not confirmed, and provision prohibition information that prohibits the provision of the product is set.
When this process is completed, the process proceeds to step S118.

In step S118, the control unit 70 performs a product provision process to provide the determined medicine from the storage unit 30. This product provision process corresponds to the product provision process (step S19) shown in Figure 6, and will be described in detail later using Figure 10. When this process is completed, the process proceeds to step S119.

In step S119, the control unit 70 performs an inventory quantity calculation process to calculate the inventory quantity of medicines stored in the storage unit 30. This inventory quantity calculation process corresponds to the inventory quantity calculation process (step S20) shown in FIG.
This inventory calculation process calculates the inventory of the provided medicine by subtracting the number of provided medicines from the inventory of the medicine before the medicine was provided. When the inventory of the medicine reaches zero, the display unit 10 displays a message indicating that the medicine is sold out. When this process is completed, the process proceeds to step S120.

In step S120, the control unit 70 performs an inventory information transmission process to transmit information on the inventory quantity of pharmaceuticals and the unique information of the product provision processing device to the product provision server 310. This allows the product provision server 310 to store the inventory quantity in the database storage unit 330 in association with the received unique information of the product provision processing device, and to grasp the inventory quantities of multiple product provision processing devices 100. When this process is completed, the process returns to step S102.

Although not shown in the figure, in addition to the main control processing shown in Figure 7, the control processing of the product provision processing device 100 also includes reception interrupt processing that is performed by receiving various information from the product provision server 310.

(Product replenishment confirmation process of product provision processing device)
Next, a detailed description will be given of the product replenishment confirmation process of the product provision processing device 100. Fig. 8 is an example of a flowchart showing the product replenishment confirmation process of the product provision processing device 100 according to the first embodiment.

As shown in FIG. 8, in step S121, the control unit 70 performs a replenishment elevator drive process in which the lift drive unit 44 moves the elevator 40 to a position facing one of the storage levels D1 to D10.
In this replenishment elevator drive process, the elevator 40 is moved to a position opposite a storage shelf D that has not been photographed by the internal camera photographing process described later, so as to move in the order from the top storage shelf D1 to the bottom storage shelf D10 (top to bottom) or from the bottom storage shelf D10 to the top storage shelf D1 (bottom to top). When this process is completed, the process proceeds to step S122.

In step S122, the control unit 70 performs internal camera photography processing during replenishment, in which the internal camera 21 photographs the storage unit 30.
In this internal camera photographing process during replenishment, the internal camera 21 photographs all storage lanes R1 to R4 in the storage shelf D facing the elevator 40, and acquires photographed images of replenished products in that storage shelf D. When this process is completed, the process proceeds to step S123.

In step S123, the control unit 70 performs a pattern matching determination process during replenishment.
In this replenishing pattern matching determination process, pattern matching is performed between the photographed replenishing product image acquired by the replenishing internal camera photographing process and a sample replenishing product image when the product is correctly replenishing in the storage section 30 in that storage shelf D, and it is determined whether or not the wrong product has been replenishing. When this process is completed, the process proceeds to step S124.

In step S124, the control unit 70 determines whether or not the pattern matching (pattern matching determination process during refilling) for all storage stages D1 to D10 has been completed.
If the control unit 70 determines that pattern matching has been completed for all storage stages D1 to D10, it transfers the processing to step S126, and if it determines that pattern matching has not been completed for all storage stages D1 to D10, it returns the processing to step S121.

In this way, by repeating the processing of steps S121 to S124, replenished product images are acquired for all storage shelves D1 to D10, and pattern matching is performed for all storage shelves D1 to D10.

In step S126, the control unit 70 performs a pattern matching display process during replenishment.
In this replenishment pattern matching display process, first, photographed replenishment product images for all storage shelves D1 to D10 are combined to generate an overall photographed replenishment product image. Then, the judgment result (normal/matching error) from the replenishment pattern matching judgment process is displayed on the display unit 10, and the overall photographed replenishment product image and the overall sample replenishment product image are displayed in comparison on the display unit 10. When this process is completed, the process proceeds to step S127.

In this embodiment, the overall photographed replenishment product image is generated from the photographed replenishment product images of all storage shelves D1 to D10 taken by the internal camera 21. However, it is also possible to have the internal camera 21 photograph all storage sections 30 at once, and use the photographed images as the overall photographed replenishment product image.

In step S127, the control unit 70 determines whether or not the pattern matching determination process at the time of restocking has determined that the wrong product has been restocked, that is, whether or not a matching error has occurred.
If the control unit 70 determines that a matching error has occurred, it proceeds to step S128, and if it determines that a matching error has not occurred, it proceeds to step S129.

In step S128, the control unit 70 performs a partial provision prohibition process to prohibit the provision of products from the storage unit 30 with a matching error.
In this partial provision prohibition process, a storage unit provision suspension state is set to suspend provision of products from the storage unit 30 that has been erroneously replenished with products as a result of the replenishment pattern matching determination process. When this process is completed, the process proceeds to step S129.

In this way, when a replenishing worker replenishing medicines, the replenishing pattern matching determination process determines whether the medicine has been correctly replenishing the storage unit 30, and if the wrong product has been replenishing, the supply of medicine from that storage unit 30 is prohibited. This prevents the wrong medicine from being replenishing due to a misconception or misunderstanding on the part of the replenishing worker, and also prevents the wrong medicine from being supplied.

In step S129, the control unit 70 determines whether or not a confirmation operation has been received from the replenisher to confirm that the photographed replenishment product image and the sample replenishment product image correspond to one storage shelf D.
If the control unit 70 determines that a confirmation operation has been received for one storage stage D, it transfers processing to step S130, and if it determines that a confirmation operation has not been received for one storage stage D, it waits until a confirmation operation is received.

In step S130, the control unit 70 performs a check data storage process for storing the storage stage D for which the confirmation operation has been accepted.
In this check data storage process, the check data is stored in association with the storage stage D for which the confirmation operation has been received, and a message indicating that the storage stage D for which the confirmation operation has been received has been checked is displayed on the display unit 10. When this process is completed, the process proceeds to step S131.

In step S131, the control unit 70 determines whether or not the check data for all the storage stages D1 to D10 has been stored.
If the control unit 70 determines that check data for all storage stages D1 to D10 has been stored, it transfers the processing to step S132, and if it determines that check data for all storage stages D1 to D10 has not been stored, it returns the processing to step S129.

In this way, by repeating the processing of steps S129 to S131, the replenisher can visually check each storage shelf D1-D10 by comparing the photographed replenishment product images and sample replenishment product images, preventing the replenisher from replenishing the wrong products.

In steps S129 to S131, the replenisher's confirmation operation is configured to check each horizontal storage row D one by one, but it may also be configured to check each vertical storage lane R for all storage lanes R1 to R4 one by one. Furthermore, the replenisher's confirmation operation may be configured to check each product one by one, or to check all products at once.

In step S132, the control unit 70 performs a total inventory information transmission process to calculate and transmit the inventory of medicines replenished in all storage units 30.
In this total inventory information transmission process, the inventory numbers of medicines replenished in all storage units 30 are calculated, and the calculated inventory numbers and the unique information of the product provision processing device are transmitted to the product provision server 310. When this process is completed, the process proceeds to step S133.

In step S133, the control unit 70 performs a product permission process to permit the provision of the product.
In this product authorization process, the replenisher is prompted to display on the display unit 10 that the replenisher has completed the replenishment work of the medicines, and is authorized to provide the medicines. Note that in the product authorization process, the storage unit provision suspension state set by the partial provision prohibition process (step S128) is not released. When this process is completed, the current product replenishment confirmation process is terminated.

In this way, in the product replenishment confirmation process of this embodiment, when a replenisher replenishes medicines, a first-stage software check is performed using the replenishment pattern matching determination process to determine whether the medicines have been correctly replenished in the storage unit 30, and a second-stage manual check (double check) is performed by the replenisher checking each storage stage D one by one. This prevents the wrong medicines from being replenished in the storage unit 30 and prevents health damage caused by taking the wrong medicines.

(Prevention of health hazards caused by OTC drugs)
Next, a description will be given of details of the process for preventing health damage to OTC medicines by the product provision processing device 100. Fig. 9 is an example of a flowchart showing the process for preventing health damage to OTC medicines by the product provision processing device according to the first embodiment.

As shown in FIG. 9, in step S141, the control unit 70 performs an ingredient information extraction process to extract ingredient information from the medicine included in the registration information of the reserved product.
In this ingredient information extraction process, ingredient information contained in various medicines stored in the storage unit 81 is referenced, and ingredient information is extracted from the medicine included in the registration information of the reserved product. When this process is completed, the process proceeds to step S142.

In step S142, the control unit 70 determines whether or not the medicine contains specific ingredients that require caution when taken, based on the extracted ingredient information of the medicine.
If the control unit 70 determines that the specific ingredient is contained, it proceeds to step S143, and if it determines that the specific ingredient is not contained, it terminates the health damage prevention process for this OTC drug.

In step S143, the control unit 70 performs a server check request process.
In this server check request process, the user's unique information, the drug's ingredient information, the unique information of the product provision processing device, etc. are sent to the product provision server 310. When this process is completed, the process proceeds to step S144.

Here, when the product provision server 310 receives the user's unique information, ingredient information of the drug to be provided, and unique information of the product provision processing device from the product provision processing device 100, it references the history information of previously provided drugs associated with the user's unique information, performs abuse prevention determination processing and contraindication prevention determination processing, and transmits the results of each determination to the product provision processing device 100 that has the unique information of the received product provision processing device.

The abuse prevention determination process references the history information of the medicines provided during a specified period associated with the user's unique information, and determines whether a specified number or more of medicines containing the ingredient information of the provided medicines have been provided within the specified period. If it is determined that a specified number or more of medicines containing the ingredient information of the provided medicines have been provided within the specified period, "ingredient abuse information" is sent to the product provision processing device 100. If it is determined that a specified number or more of medicines containing the ingredient information of the provided medicines have not been provided within the specified period, "normal dosing information" is sent to the product provision processing device 100.

In the incompatibility prevention determination process, past ingredient information is extracted from the medicines provided during a specific period associated with the user's unique information, and information on incompatible combinations of various types of ingredient information that are contraindicated for combined use is referenced to determine whether the ingredient information of the provided medicine and the past ingredient information constitute an incompatible combination. If it is determined that an incompatible combination exists, "information indicating that a contraindication exists" is transmitted to the product provision processing device 100, and if it is determined that an incompatible combination does not exist, "information indicating that a contraindication does not exist" is transmitted to the product provision processing device 100.
The information on cautionary combinations of various kinds of ingredient information that require caution in combination is also referred to, and a determination is made as to whether the ingredient information of the drug to be provided and the past ingredient information constitute a cautionary combination. If it is determined that a cautionary combination exists, "contraindication warning information" is transmitted to the product provision processing device 100, and if it is determined that a cautionary combination does not exist, "no caution information" is transmitted to the product provision processing device 100.

Returning to the processing of the product provision processing device 100, in step S144, the control unit 70 determines whether or not to provide products containing a predetermined number or more of specific ingredients for a predetermined period of time based on the information transmitted from the product provision server 310. Specifically, by receiving "ingredient abuse information" from the product provision server 310, the control unit 70 determines to provide products containing a predetermined number or more of specific ingredients for a predetermined period of time, and by receiving "normal dosing information" from the product provision server 310, the control unit 70 determines not to provide products containing a predetermined number or more of specific ingredients for a predetermined period of time.
If the control unit 70 determines that products containing a predetermined number or more of specific ingredients will be provided during a predetermined period, it transfers processing to step S148, and if it determines that products containing a predetermined number or more of specific ingredients will not be provided during a predetermined period, it transfers processing to step S145.

In step S145, the control unit 70 determines whether or not to provide a medicine containing ingredients that will be in a contraindicated combination during the specific period, based on the information transmitted from the product provision server 310. Specifically, the control unit 70 determines to provide a medicine containing ingredients that will be in a contraindicated combination during the specific period by receiving "contraindication information" from the product provision server 310, and determines not to provide a medicine containing ingredients that will be in a contraindicated combination during the specific period by receiving "no contraindication information" from the product provision server 310.
If the control unit 70 determines that a medicine containing ingredients that are incompatible with one another will be provided during a specific period, it transfers processing to step S148; if it determines that a medicine containing ingredients that are incompatible with one another will not be provided during a specific period, it transfers processing to step S146.

In step S146, the control unit 70 determines whether or not to provide a medicine containing ingredients that constitute a cautionary combination during the specific period, based on the information transmitted from the product provision server 310. Specifically, the control unit 70 determines to provide a medicine containing ingredients that constitute a cautionary combination during the specific period by receiving "contraindication warning information" from the product provision server 310, and determines not to provide a medicine containing ingredients that constitute a cautionary combination during the specific period by receiving "no warning information" from the product provision server 310.
If the control unit 70 determines that a medicine containing ingredients that constitute a cautionary combination will be provided during the specified period, it proceeds to step S147, and if it determines that a medicine containing ingredients that constitute a cautionary combination will not be provided during the specified period, it terminates the current process for preventing health damage to OTC medicines.

In step S147, the control unit 70 sets combination warning display data that causes the display unit 10 to display a warning about the use of the currently provided drug in combination with ingredients of a previously provided drug. When this process is completed, the current OTC drug health hazard prevention process is completed. Note that even if the combination warning display data is set, the drug will still be provided, as described below.

In addition, when providing a medicine containing ingredients that are subject to caution during a specific period, a message will be displayed urging caution when combining the current medicine with ingredients from medicines provided in the past, alerting users and preventing health damage.

In step S148, the control unit 70 performs a provision suspension process to stop the provision of pharmaceuticals when providing a product containing a predetermined number or more of specific ingredients during a predetermined period, or when providing a pharmaceutical product containing ingredients that constitute a cautionary combination during a predetermined period. In this provision suspension process, provision prohibition information that prohibits the provision of the product is set. When this process is completed, the current OTC pharmaceutical health hazard prevention process is completed.

In this way, if a product containing a specific ingredient is provided more than a specified number of times within a specified period, the provision of the drug will be suspended, preventing abuse by users of drugs containing the same active ingredient and preventing health damage. In particular, the abuse prevention determination process determines whether a specified number or more of drugs containing the ingredient information of the drug being provided have been provided within a specified period. This more appropriately prevents abuse by users of drugs containing the same active ingredient and more effectively prevents health damage without being limited to the same drug or distinguishing between original and generic drugs.

In addition, if the pharmaceutical product being provided this time is contraindicated for use in combination with ingredients of a pharmaceutical product provided in the past, the provision of the pharmaceutical product will be suspended, thereby preventing health damage caused by contraindications for combined use.

(Product provision processing by product provision processing device)
Next, a description will be given of details of the product provision process of the product provision processing device 100. Fig. 10 is an example of a flowchart showing the product provision process of the product provision processing device according to the first embodiment.

As shown in FIG. 10, in step S151, the control unit 70 determines whether or not provision prohibition information has been set.
If the control unit 70 determines that the provision prohibition information has been set, it proceeds to step S152, and if it determines that the provision prohibition information has not been set, it proceeds to step S153.

In step S152, the control unit 70 performs a drug error display process to cause the display unit 10 to display a message that provision of the drug is prohibited.
In this drug error display process, the display unit 10 displays that the provision of the drug is prohibited based on the information resulting from the setting of the provision prohibition information (second denial information indicating the pharmacist's denial, ingredient abuse information, and contraindication information). When this process is completed, the current product provision process is terminated.

In step S<b>153 , the control unit 70 performs an elevator outward drive process to move the elevator 40 to a position facing the storage unit 30 .
In this elevator outward drive process, the position of storage level D of the storage unit 30 where the medicine to be provided is stored is calculated, and the elevator 40 is moved by the up-down drive unit 44 to the calculated position of storage level D. When this process is completed, the process proceeds to step S154.

In step S154, the control unit 70 performs an internal camera photographing process in which the internal camera 21 photographs the medicines stored in the storage unit 30 that are to be provided this time.
In this internal camera photographing process, the internal camera 21 photographs the medicines to be provided this time stored in the storage unit 30 facing the elevator 40, and obtains a provided product image of the medicines to be provided this time. When this process is completed, the process proceeds to step S155.

In step S155, the control unit 70 performs a pattern matching determination process.
In this pattern matching determination process, pattern matching is performed between the acquired provided product image and a sample product image when the correct product is stored in the storage unit 30, and it is determined whether or not an incorrect medicine is stored. When this process is completed, the process proceeds to step S156.

In step S156, the control unit 70 determines whether or not the pattern matching determination process has determined that the wrong medicine has been stored, that is, whether or not a matching error has occurred.
If the control unit 70 determines that a matching error has occurred, it proceeds to step S157, and if it determines that a matching error has not occurred, it proceeds to step S159.

In step S157, the control unit 70 performs a provision error display process to display on the display unit 10 that the medicine to be provided has been stored incorrectly and the medicine cannot be provided. After completing this process, the process proceeds to step S158.

In step S158, the control unit 70 performs a partial provision prohibition process to prohibit the provision of products from the storage unit 30 with a matching error.
In this partial provision prohibition process, a storage unit provision stop state is set in which provision of products from the storage unit 30 in which the incorrect medicine is stored is stopped by the pattern matching determination process. This stops future provision of products from the storage unit 30 in which the incorrect medicine is stored. Then, the elevator 40 is returned to a position opposite the product take-out opening 12 by the lift drive unit 44. When this process is completed, the current product provision process is terminated.

In this way, even when a medicine is provided, a pattern matching judgment process is used to check immediately beforehand whether the wrong medicine has been stored in the storage unit 30, preventing the wrong product from being provided. Furthermore, when medicines are replenished, a double check is performed to ensure that the wrong medicine has not been replenished in the storage unit 30. However, even if the wrong medicine has been replenished at the back of the storage unit 30, it is possible to discover that the wrong medicine has been stored in the storage unit 30 immediately before the medicine is provided, allowing the correct medicine to be provided more accurately.

Furthermore, even if the pattern matching determination process determines that the incorrect medicine is stored in the storage unit 30, the provision of medicines from the storage unit 30 where the incorrect medicine is stored is stopped without stopping the provision of all products by the product provision processing device 100. This allows the provision of products from the storage unit 30 that has been correctly replenished with medicines to continue, thereby preventing a decrease in the operating rate of product provision by the product provision processing device 100.

This is because the internal camera 21 photographs the medicines to be provided that are stored in the storage unit 30. If the internal camera 21 photographs the medicines placed on the tray 41 and performs pattern matching between the image of the medicines placed on the tray 41 and the sample product image, a matching error would force the elevator 40 to stop operating or the product outlet 12 to close, thereby halting the provision of all products by the product provision processing device 100.

In the first product supply processing device 100A, in step S159, the control unit 70 performs a purchase price payment confirmation process.
In this purchase price payment confirmation process, the purchase price of the medicine to be provided is calculated, and the payment from the user is confirmed via the monetary information input/output unit 60. If the payment from the user is sufficient to cover the purchase price, the process proceeds to step S160 to provide the medicine to the user. If the payment from the user exceeds the purchase price, the change is calculated and the calculated change is discharged into the change outlet 18.

Furthermore, since the second product provision processing device 100B installed in a retail store such as a convenience store does not have a payment unit, the above-mentioned purchase price payment confirmation process is not performed and processing proceeds to step S160. As described above, for pharmaceuticals provided by the second product provision processing device 100B, accounting processing will be carried out at the retail store where the second product provision processing device 100B is installed.

In step S<b>160 , the control unit 70 performs a conveyor driving process for driving the conveyor 31 .
In this conveyor driving process, the belt driving unit 34 provided on the conveyor 31 of the storage unit 30 in which the medicines to be provided are stored is driven to transport the medicines to be provided stored in the storage unit 30 to the elevator 40. By this conveyor driving process, the medicines to be provided stored in the storage unit 30 are placed on the tray 41 of the elevator 40. When this process is completed, the process proceeds to step S161.

In step S161, the control unit 70 performs an elevator return drive process in which the lift drive unit 44 moves the elevator 40 to a position opposite the product take-out opening 12. When this process is completed, the process proceeds to step S162.

In step S162, the control unit 70 performs a product outlet opening process to open the opening/closing door 13 using the opening/closing drive unit 91. This product outlet opening process allows the user to receive medicines provided by the product provision processing device 100 from the product outlet 12. When this process is completed, the process proceeds to step S163.

In step S163, the control unit 70 performs a provision display process to cause the display unit 10 to display that the provision of the medicine has been completed.
In this provision display process, if the concomitant use warning display data is set, the display unit 10 displays a message urging caution against combining the currently provided drug with ingredients of a previously provided drug when the drug has been provided, and if the concomitant use warning display data is not set, the display unit 10 displays a message indicating that the drug has been normally provided. When this process is completed, the current product provision process is terminated.

In this embodiment, the product provision server 310 is configured to perform the abuse prevention determination process and the contraindication prevention determination process. However, the product provision processing device 100 may also be configured to obtain information on previously provided pharmaceuticals associated with the user's unique information from the product provision server 310, and perform the abuse prevention determination process and the contraindication prevention determination process.

[Display screen of user terminal device]
A description will be given of an example of a display screen displayed on the terminal display unit 204 of the above-described user terminal device 200. Fig. 11 shows an example of a display screen displayed on the terminal display unit of the user terminal device according to the first embodiment.

Figure 11(a) is an example of a product selection display screen that is displayed on the terminal display unit 204 of the user terminal device 200 when the user terminal device 200 selects a medicine as a reserved product (e.g., step S2).

As shown in FIG. 11(a), the product selection display screen displays at least a first button image that allows the user to select a purchasing route for directly selecting and purchasing a medicine, and a second button image that allows the user to select a purchasing route for selecting a symptom and purchasing a medicine. The user decides on a pharmaceutical purchasing route by touching the first button image or the second button image, narrows down the pharmaceuticals based on various selection information, and decides on the narrowed-down pharmaceuticals as pre-order items.

Figure 11(b) is an example of a reservation item confirmation display screen that is displayed on the terminal display unit 204 of the user terminal device 200 when the user decides on the item to reserve (step S2, etc.).

As shown in FIG. 11(b), the reserved item confirmation display screen displays information about the drug to be reserved, a "Yes" button image for confirming the reserved item, and a "No" button image for canceling the reserved item. Furthermore, if the drug to be reserved is a specific drug (e.g., a Category 1 drug), a medical interview transition image is displayed informing the user that a medical interview with a pharmacist will be conducted (e.g., text stating "Category 1 drugs require the approval of a pharmacist, and a QA with the pharmacist will be conducted"). The user confirms the reserved item by touching the "Yes" button image, and if the drug to be reserved is a specific drug, a medical interview with a pharmacist will be conducted.

Figure 11 (c) shows an example of a medical interview display screen displayed on the terminal display unit 204 of the user terminal device 200 when the pharmacist is conducting a medical interview with the user (e.g., step S5).

As shown in FIG. 11(c), the medical interview display screen displays the contents of the pharmacist's conversation and the user's conversation in a text-based manner, such as via chat. While this embodiment is configured to have a text-based conversation, such as via chat, the conversation may be voice-only or via video call. The pharmacist will approve a specific drug through the medical interview with the user via the pharmacist terminal device 340.

Figure 11 (d) shows an example of a reservation result list display screen that is displayed on the terminal display unit 204 of the user terminal device 200 by the reservation result list display process (step S7) after a specific medicine has been approved by a pharmacist and registration information for the reserved product and location information for the product provision processing device are received from the product provision server 310.

As shown in FIG. 11(d), the reservation result list display screen displays an explanatory image showing the registration information for the reserved item, and also displays a map image of the surrounding area and a location information image (e.g., a star mark) of the product provision processing device 100 where the reserved item can be picked up, based on the current location information of the user terminal device 200. The user can view the location information image and move to the location of the product provision processing device 100 where the reserved item can be picked up.

In addition to the location information image of the product provision processing device 100 where the reserved product can be received, the number of reserved products stored in that product provision processing device 100 may also be displayed. In this configuration, the product provision server 310 transmits to the user terminal device 200 information on the inventory number of that product provision processing device 100 in addition to the location information of the product provision processing device 100.

[Display screen of product provision processing device]
An example of a display screen displayed on the display unit 10 of the product provision processing device 100 will be described.

(Display screen when picking up reservation)
First, with reference to Fig. 12 and Fig. 13, a description will be given of a display screen displayed on the display unit 10 when a reserved product is received in the product provision processing device 100. Fig. 12 and Fig. 13 show an example of a display screen displayed on the display unit 10 when a reserved product is received in the product provision processing device 100 according to the first embodiment.

Figure 12(a) shows an example of a reception display screen displayed on the display unit 10 of the product provision processing device 100 when the reception waiting process for receiving operations from the user is being performed (steps S11 and S102).

As shown in FIG. 12(a), the reception display screen displays a purchase operation image for accepting a product purchase operation from the user and a receipt operation image for accepting a reserved product receipt operation from the user. The user performs a product purchase operation by touching the purchase operation image, and performs a reserved product receipt operation by touching the receipt operation image.

Figure 12(b) shows an example of an authentication code display screen that is displayed on the display unit 10 of the product provision processing device 100 when the user performs an operation to receive the reserved product (steps S12 and S103).

As shown in FIG. 12(b), authentication code information such as a QR code is displayed on the authentication code display screen. The user reads the authentication code information displayed on the display unit 10 of the product provision processing device 100 using the user terminal device 200 and accesses the product provision server 310.

Figure 12 (c) shows an example of an approval display screen that is displayed on the display unit 10 of the product provision processing device 100 when the user terminal device 200 accesses the product provision server 310 based on the authentication code information and the pharmacist is approving the reserved product (step S55).

As shown in Figure 12(c), the approval display screen indicates that the pharmacist is currently approving the reserved item and is waiting.

Figure 12 (d) shows an example of a provided product confirmation display screen that is displayed on the display unit 10 of the product provision processing device 100 when the pharmacist completes the approval process for the reserved product and receives second approval information indicating the pharmacist's approval as second approval result information from the product provision server 310 (steps S18 and S117).

As shown in FIG. 12(d), the provided product confirmation display screen displays information about the medicine to be provided, a "Yes" button image for confirming the medicine to be provided, and a "No" button image for canceling the medicine to be provided. The user confirms the medicine to be provided by touching the "Yes" button image, and the product provision processing device 100 performs the product provision process (steps S19 and S118) to provide the medicine.

Figure 13 (a) shows an example of a normal provision completion display screen that is displayed on the display unit 10 of the product provision processing device 100 by the provision display process (step S163) when a pharmaceutical product is provided when the concomitant use warning display data is not set.

As shown in Figure 13(a), the successful delivery completion display screen displays a delivery completion image (e.g., the text "Please collect your product from the product outlet") to notify the user that the medicine has been delivered.

Figure 13 (b) shows an example of a warning provision completion display screen that is displayed on the display unit 10 of the product provision processing device 100 by the provision display process (step S163) when the concomitant use warning display data has been set and the medicine is provided.

As shown in Figure 13(b), the warning provision completion display screen displays, in addition to the provision completion image, a combination use warning image informing the user that the currently provided drug should not be used in combination with ingredients of drugs previously provided (for example, the text "Please be careful not to use ingredient A of drug ABC provided this time in combination with ingredient B of drug Z").

Figure 13 (c) shows an example of a delivery error display screen that is displayed on the display unit 10 of the product delivery processing device 100 by the delivery error display process (step S157) when a medicine is not provided due to a matching error when providing the medicine.

As shown in FIG. 13(c), the supply error display screen displays a supply prohibition image (e.g., the text "This drug cannot be provided") notifying that the drug cannot be provided, along with an error notification image (e.g., the text "Corresponding drug not found") notifying of a matching error. The supply error display screen also displays a first corresponding image corresponding to the matching error (e.g., the text "Please change the vending machine from which you make your purchase").

Figure 13 (d) is an example of an abuse prevention display screen that is displayed on the display unit 10 of the product provision processing device 100 by the drug error display process (step S152) when a drug is not provided due to abuse prevention when providing the drug.

As shown in FIG. 13(d), the abuse prevention display screen displays an abuse prevention notification image (e.g., the text "To prevent abuse of specific ingredients") informing users of abuse prevention along with the prohibited provision image. The abuse prevention display screen also displays a second corresponding image (e.g., the text "Please consult a pharmacist at a pharmacy before purchasing") that corresponds to abuse prevention.

Figure 13(e) shows an example of a contraindication for combination display screen that is displayed on the display unit 10 of the product provision processing device 100 by the drug error display process (step S152) when a drug is not provided due to a contraindication for combination when providing the drug.

As shown in FIG. 13(e), the contraindication display screen displays a contraindication notification image (e.g., text "Component A of drug ABC and component C of drug X are contraindicated for use together") that notifies users of the contraindication, along with the prohibited use image. The contraindication display screen also displays a second image corresponding to the contraindication (e.g., text "Please consult a pharmacist at a pharmacy before purchasing").

(Display screen during replenishment work)
Next, a display screen displayed on the display unit 10 when a replenishment operation is performed in the product provision processing device 100 will be described with reference to Fig. 14. Fig. 14 shows an example of a display screen displayed on the display unit 10 when a replenishment operation is performed in the product provision processing device 100 according to the first embodiment.

Figure 14 (a) shows an example of a judgment result display screen that is displayed on the display unit 10 of the product provision processing device 100 when the replenisher has completed the replenishment work of medicines and the replenishment pattern matching display process is performed (step S126).

As shown in Figure 14(a), the judgment result display screen displays a judgment image of the judgment result from the replenishment pattern matching judgment process (for example, the text "Pattern matching: normal"), as well as a comparison of the entire photographed replenishment product image and the entire sample replenishment product image. The replenisher can understand the judgment result from the replenishment pattern matching judgment process on the judgment result display screen.

Furthermore, the judgment result display screen displays a confirmation instruction image (for example, text such as "Compare the sample image with the photographed image and check (touch) each row in the photographed image") that prompts the replenisher to confirm that the photographed replenishment product images for each storage shelf D correspond to the sample replenishment product images. The replenisher will confirm that the storage shelves D in the photographed replenishment product images correspond to the storage shelves D in the sample replenishment product images one by one, and then touch the storage shelves D in the photographed replenishment product images that have been confirmed.

Figure 14 (b) shows an example of a check display screen that is displayed on the display unit 10 of the product provision processing device 100 when the replenisher checks storage row D1, which is the top row of the photographed replenishment product images (step S130).

As shown in Figure 14(b), on the check display screen, when the storage row D1 of the photographed replenishment product image is touched by the replenisher, the background color of storage row D1 of the photographed replenishment product image changes and a check mark is displayed to the right of storage row D1 of the photographed replenishment product image, indicating that a confirmation operation has been received confirming that storage row D1 of the photographed replenishment product image corresponds to storage row D1 of the sample replenishment product image.

Figure 14 (c) is an example of a checked display screen that is displayed on the display unit 10 of the product provision processing device 100 when all storage shelves D of the photographed replenishment product images have been checked by the replenisher (step S130).

As shown in Figure 14 (c), on the checked display screen, the background color of all storage shelves D in the photographed replenishment product images changes, and a check mark is displayed to the right of all storage shelves D in the photographed replenishment product images. Also, on the checked display screen, a check completion notification image (e.g., the text "Replenishment check completed") is displayed to notify that checking of all storage shelves D in the photographed replenishment product images has been completed.

Figure 14 (d) shows an example of a replenishment work completion display screen that is displayed on the display unit 10 of the product provision processing device 100 when all storage shelves D of the photographed replenishment product images have been checked and the replenisher's pharmaceutical replenishment work is complete (step S133).

As shown in Figure 14 (d), the restocking work completion display screen displays a restocking work completion notification image (e.g., the words "Thank you for your hard work on the restocking work") to notify the restocker that the restocking work of medicines has been completed.

As described above, in this embodiment, when a user selects a specific product (specific medicine) as a reserved product from the user terminal device 200, the user terminal device 200 conducts an interview with the person in charge (pharmacist) regarding the specific product, and the person in charge approves the specific product, and the user terminal device 200 displays the location information of the product provision processing device 100 that can provide the reserved product.
As a result, the user terminal device 200 can conduct interviews with the person in charge, making it easier to protect the user's privacy, and the user can know where to go to receive the reserved product from the product provision processing device 100, thereby improving the convenience of product provision.

Furthermore, as product provision processing devices 100 that can provide reserved products, product provision processing devices that have the product corresponding to the reserved product in stock and whose storage unit 30 storing the product corresponding to the reserved product is in a storage unit provision permitted state are extracted. This reduces the chances that the reserved product cannot be received when the product provision processing device 100 is sold out or is no longer in a provision state.

In this embodiment, when a user selects a reserved product from the user terminal device 200, the product provision processing device 100 that will receive the reserved product is not selected. When the user receives the reserved product from the product provision processing device 100, the user terminal device 200 reads the authentication code information displayed on the product provision processing device 100 and transmits registration information and the like of the reserved product to the product provision server 310. The product provision server 310 transfers the registration information and the like of the reserved product to the product provision processing device 100, and the product provision processing device 100 permits the provision of the reserved product based on the registration information and the like of the reserved product.
Therefore, when a user selects a reserved product from the user terminal device 200, the reserved product can be received from any product provision processing device 100 that can provide the reserved product, improving the convenience of product provision. Furthermore, since the reserved product is not selected in advance in the product provision processing device 100, the burden of processing to secure the reserved product (controlling sold-out by subtracting the reserved product, canceling the reserved product due to the reservation deadline, inventory management processing, etc.) can be reduced, and the loss of opportunity to provide the product to a third party due to sold-out due to securing the reserved product can be suppressed, thereby maintaining the operation of product provision.

Furthermore, in this embodiment, when a user selects a specific product (specific medicine) as a reserved product from the user terminal device 200, the person in charge performs a first approval process (first pharmacist approval process in step S53), and when the user receives the reserved product from the product provision processing device 100, the person in charge performs a second approval process (second pharmacist approval process in step S55).
This makes it possible to prevent a user who receives a reserved product from the product provision processing device 100 from impersonating a user who has decided to reserve the product from the user terminal device 200 and receiving the reserved product.

Furthermore, the system is configured so that a portion of the incentive is paid to the responsible person when the responsible person performs the first approval process (first incentive payment process in step S36), and the remaining amount of the incentive is paid when the reserved product is provided from the product provision processing device 100 after the responsible person performs the second approval process (second incentive payment process in step S47).
Therefore, even if a user decides on a reserved product but cancels the reserved product and the product is not actually provided from the product provision processing device 100, part of the incentive is paid when the first approval process is performed, so that the approval work of the person in charge is not all wasted due to the cancellation of the reserved product, and the approval work of the person in charge is actively performed, thereby making it possible to improve the operating rate of the product provision system 1.

Furthermore, the first approval process by the responsible person is performed by the responsible person who first sends the medical interview application information to the pharmacist server 320 (first come, first served).
This reduces the waiting time for the person in charge to participate in the user interview, and further improves the availability of the product provision system 1.

Furthermore, the unit price of the incentive paid to the person in charge is set based on the number of times the person in charge accesses the server 300, with the unit price of the incentive being set higher during times when the number of times the person in charge accesses is low, such as late at night or on holidays, and lower during times when the number of times the person in charge accesses is high, such as during the day or on weekdays (step S36).
This allows the setting of incentive unit prices during times of low access to be automatically controlled, allowing approval work by responsible persons to be carried out stably during late night hours, holidays, etc., further improving the operating rate of the product provision system 1.

In addition, in this embodiment, when a replenisher performs the replenishment work of medicines, pattern matching is performed between the photographed replenishment product image and the sample replenishment product image (step S123) to determine whether the medicines have been correctly replenished in the storage unit 30, and if the wrong product has been replenished, the provision of medicines from that storage unit 30 is prohibited (steps S127, S128).
This prevents the wrong medicine from being refilled due to the refiller's mistaken belief or misunderstanding, and prevents the wrong medicine from being provided, thereby preventing health hazards caused by taking the wrong medicine.

Furthermore, when pattern matching is performed between the photographed replenishment product images and the sample replenishment product images, the display unit 10 of the product provision processing device 100 displays a comparison of the photographed replenishment product images and the sample replenishment product images, along with the pattern matching determination result between the photographed replenishment product images and the sample replenishment product images (step S126, display screen of FIG. 14). In addition, the replenisher is prompted to perform a confirmation operation to confirm that each storage shelf D of the photographed replenishment product images corresponds to each storage shelf D of the sample replenishment product images (steps S129 to S131, display screen of FIG. 14).
Therefore, a first stage check by software is performed by pattern matching to check whether the correct medicines have been replenished in the storage unit 30, and a second stage check (double check) is performed manually by the replenisher checking each storage stage D, thereby preventing the wrong medicines from being replenished in the storage unit 30 and the wrong medicines from being provided. This makes it possible to prevent health hazards caused by taking the wrong medicines.

In addition, in this embodiment, when the product provision processing device 100 provides a medicine, it performs pattern matching between the provided product image and the sample product image (step S155) to determine whether the correct medicine is stored in the storage unit 30, and if the incorrect medicine is stored, it prohibits the provision of the medicine from that storage unit 30 (steps S156, S158).
Therefore, when providing a medicine, it is possible to check immediately beforehand whether the wrong medicine has been stored in the storage unit 30, thereby preventing the wrong medicine from being provided. This makes it possible to prevent health hazards caused by taking the wrong medicine. Furthermore, even when a medicine is refilled, a double check is performed to ensure that the wrong medicine has not been refilled in the storage unit 30. Even if the wrong medicine has been refilled deep inside the storage unit 30, it is possible to discover that the wrong medicine has been stored in the storage unit 30 immediately before providing the medicine, thereby making it possible to provide the correct medicine more accurately.

Furthermore, in this embodiment, even when a replenisher performs the task of replenishing medicines, or when pattern matching is performed when the product provision processing device 100 provides medicines and determines that the wrong medicine is stored in the storage unit 30, the product provision processing device 100 stops providing medicines from the storage unit 30 where the wrong medicine is stored, without stopping the provision of all products.
Therefore, it is possible to continue providing products from the storage unit 30 in which medicines are correctly stored, and to prevent a decrease in the operating rate for providing products.

In addition, in this embodiment, when the product provision processing device 100 provides a pharmaceutical product, it determines whether or not to provide a product containing a predetermined number or more of specific ingredients for a predetermined period of time (step S144), and if it determines that a product containing a predetermined number or more of specific ingredients will be provided for a predetermined period of time, it stops providing the pharmaceutical product (step S148).
Therefore, if more than a specified number of drugs containing the same active ingredient are to be supplied within a specified period, the supply of the drug will be suspended, thereby preventing abuse by users of drugs containing the same active ingredient and preventing health hazards. In particular, without being limited to the same drug or distinguishing between original and generic drugs, abuse by users of drugs containing the same active ingredient can be more appropriately prevented and health hazards can be prevented.

In addition, in this embodiment, when the product provision processing device 100 provides a pharmaceutical product, it determines whether or not to provide a pharmaceutical product containing ingredients that would be in an incompatible combination during a specific period (step S145), and if it determines that a pharmaceutical product containing ingredients that would be in an incompatible combination during a specific period will be provided, it stops providing the pharmaceutical product (step S148).
Therefore, if the medicine being provided this time is contraindicated for use in combination with ingredients of a medicine provided in the past, the provision of the medicine will be suspended, thereby preventing health damage caused by contraindications for combined use.

In addition, in this embodiment, when the product provision processing device 100 provides a medicine, it determines whether or not to provide a medicine containing ingredients that would be a cautionary combination during a specific period (step S146), and if it determines that a medicine containing ingredients that would be a cautionary combination during a specific period will be provided, it issues a warning to caution against using the medicine currently provided in combination with ingredients of medicines provided in the past (steps S147, S152).
Therefore, a warning will be issued urging caution when using the medicine provided this time in combination with ingredients from medicines provided in the past, which will help prevent health damage caused by the medicine provided this time.

In other words, in this embodiment, when a user selects a specific medicine as a reserved item, a "first check" is performed by a pharmacist to ensure that the medicine selected by the user is the appropriate medicine; when the medicine is replenished by a replenisher, a "second check" is performed by pattern matching the photographed replenished product image with the sample replenished product image to ensure that it is the correct medicine; and a "third check" is performed by the replenisher's confirmation operation; and when the medicine is provided, a "fourth check" is performed by pattern matching the provided product image with the sample product image to ensure that it is the correct medicine. This more reliably prevents health damage caused by taking the wrong medicine for the user's condition.

Furthermore, when providing pharmaceuticals, a "fifth check" will be carried out to prevent abuse by users of pharmaceuticals containing the same active ingredients, a "sixth check" to determine whether the pharmaceutical is contraindicated for use in combination with ingredients from pharmaceuticals previously provided, and a "seventh check" to determine whether the pharmaceutical requires caution when used in combination with ingredients from pharmaceuticals previously provided. This will make it possible to more firmly prevent health damage from occurring when taking pharmaceuticals.

In addition, in embodiment 1, when a user receives a reserved product (medicine) from the product provision processing device 100, the product provision processing device 100 displays authentication code information, and the user terminal device 200 reads the authentication code information, so that the medicine is provided from the product provision processing device 100.
However, when a user receives a reserved product (medicine) from the product provision processing device 100, the user terminal device 200 may display code information, and the product provision processing device 100 may read the code information, thereby providing the medicine from the product provision processing device 100.

[Embodiment 2]
The product provision system 1 and product provision processing device 100 of embodiment 2 are configured so that when a user receives a reserved product (medicine) from the product provision processing device 100, the user terminal device 200 displays approval code information, and the product provision processing device 100 reads the approval code information, thereby providing the medicine from the product provision processing device 100.
The product provision system 1 and the product provision processing device 100 according to the second embodiment will be described below.

The external configuration of the product provision processing device 100 and the internal configuration of the product provision system 1 according to the second embodiment are the same as the external configuration of the product provision processing device 100 according to the first embodiment (see Figures 1 to 3) and the internal configuration of the product provision system 1 (see Figure 5). The product provision system 1 and product provision processing device 100 according to the second embodiment differ in part in the processing content compared to the product provision system 1 and product provision processing device 100 according to the first embodiment. In describing the processing of the second embodiment, the same processes as those of the first embodiment are denoted by the same symbols and numbers, and detailed descriptions of those processes will be omitted.

[Sequence diagram of product provision system according to the second embodiment]
Figure 15 is an example of a sequence diagram showing the processing transition when a reservation is accepted by the product provision system of embodiment 2, and Figure 16 is an example of a sequence diagram showing the processing transition when a reservation is received by the product provision system of embodiment 2.

(Sequence at the time of accepting a reservation in the second embodiment)
As shown in FIG. 15, when the reserved product registration process (see step S38) is completed, the product providing server 310 performs an approval code information transmission process (step S201).
In this authorization code information transmission process, authorization code information and the like are transmitted to the user terminal device 200. This "authentication code information" includes reservation connection information (URL) for connecting to the product providing server 310, user specific information, and registration information for the reserved product (reserved medicine, number of reserved items, reservation completion time, and specific information of the pharmacist who interviewed the patient).

When the user terminal device 200 receives the approval code information and the like from the product providing server 310, the user terminal device 200 performs an approval code acquisition process (step S202).
In this authorization code acquisition process, the received authorization code information and the like are stored in the terminal storage unit 202 .

(Sequence for receiving a reservation in the second embodiment)
As shown in FIG. 16, the product provision processing device 100 performs a reception standby process for receiving an operation from a user or the like (step S203).
In this reception waiting process, the type of operation from the user is determined, and if the user performs an operation to receive the reserved item, the process proceeds to the approval code information reading process (step S205).

The user terminal device 200 reads the authorization code information, etc. stored in the terminal storage unit 202, and performs an authorization code information display process to display the authorization code information on the terminal display unit 204 (step S204).

When the user performs an operation to receive the reserved product, the product provision processing device 100 performs an approval code information reading process (step S205).
In the authorization code information reading process, the authorization code information displayed on the terminal display unit 204 of the user terminal device 200 is read, the read authorization code information is analyzed, and the analyzed authorization code analysis information (reservation connection information, user-specific information, registration information for the reserved product, etc.) is obtained.

After the user photographing process in step S16, the product provision processing device 100 performs a provision application process (step S206).
In this supply application process, the registration information of the reserved product, supply application information, user image, user specific information, etc. are transmitted to the product supply server 310 .

In this way, the product provision system 1 and product provision processing device 100 according to the second embodiment also allow a user to select a reserved product (pharmaceutical product) using the user terminal device 200, and receive the selected reserved product (pharmaceutical product) from the product provision processing device 100. Thus, the second embodiment can also achieve the same functions and effects as the first embodiment.

[Other variations]

In the first and second embodiments, the product provision processing device 100 is configured to provide pharmaceutical products, but it may also provide products such as alcohol and tobacco. When providing products such as alcohol and tobacco, the pharmacist who would act as the sales manager when the product is pharmaceuticals will take over.

Furthermore, in embodiments 1 and 2, the product providing processing device 100 is not equipped with a refrigerator, but it may be configured to be equipped with a refrigerator so that the inside of the product providing processing device 100 can be adjusted to an appropriate temperature.

In embodiments 1 and 2, when the first product provision processing device 100A is used, payment for the purchase of the product is made through the financial information input/output unit 60 provided in the first product provision processing device 100A, and when the second product provision processing device 100B is used, the payment is processed at the retail store where the second product provision processing device 100B is installed.
However, the system may be configured so that online payment is made in advance at the user terminal device 200 before receiving the reserved product from the product provision processing device 100 .

In embodiments 1 and 2, when the product provision processing device 100 provides a medicine, it photographs the medicine to be provided, performs pattern matching between the photographed image of the provided product and a sample product image, and if the wrong medicine is stored, prohibits the provision of the medicine from that storage unit 30 (steps S155, S156, S158, etc.).
However, after the product provision processing device 100 provides a medicine, it may be configured to photograph the medicine to be provided next, perform pattern matching between the photographed provided product image and the sample product image, and if the wrong medicine is stored, prohibit the provision of medicine from that storage unit 30. In other words, pattern matching may be performed when the device is in operation and able to provide products other than when a replenisher is performing the replenishment work of replenishing products in the storage unit 30.

In embodiments 1 and 2, when a user decides on a reserved item from the user terminal device 200, a first approval by the pharmacist (first pharmacist approval process in step S53) is performed, and when the user receives the reserved item from the product provision processing device 100, a second approval by the pharmacist (second pharmacist approval process in step S55) is performed. However, when a user receives the reserved item from the product provision processing device 100, a second approval by the pharmacist does not have to be performed.

In the first and second embodiments, if the medicine determined as the reserved product is a regular medicine (e.g., a Class 2 or Class 3 medicine), the regular medicine is provided without the need for approval from a pharmacist.
However, even if the medicine determined as the reserved product is a regular medicine, a pharmacist may perform a simple check and the regular medicine may be provided subject to the pharmacist's approval.

In the first and second embodiments, the second product provision processing device 100B has the storage unit 30 for storing products, and is configured to be installed in a retail store such as a convenience store.
However, the second product provision processing device 100B may be configured to stock products within the store without having a storage unit 30 for storing products, and to perform processes (such as confirmation of reserved products and pharmacist authentication) with the user terminal device 200 and the server 300 without performing product provision processing. In other words, the second product provision processing device 100B may be replaced with a POS terminal (self-checkout or semi-self-checkout) installed in front of the cash register of a store such as a convenience store.

It will be clear to those skilled in the art that the above-mentioned embodiments, including their modifications, can be applied to each other's technologies.

The above description is intended to be illustrative and not limiting. Thus, it will be apparent to those skilled in the art that modifications can be made to the embodiments of the present invention without departing from the scope of the claims.

Terms used in this specification and claims should be construed as open-ended terms. For example, the term "including" should be interpreted as "not limited to what is described as including." The term "comprises" should be interpreted as "not limited to what is described as comprising." The term "having" should be interpreted as "not limited to what is described as having."

1 Product provision system 30 Storage unit 100 Product provision processing device 100A First product provision processing device 100B Second product provision processing device 200 User terminal device 300 Server 310 Product provision server 320 Pharmacist server 330 Database storage unit 340 Pharmacist terminal device R1 to R4 Storage lanes D1 to D10 Storage stages

Claims (2)

In a product provision system, a user terminal device operated by a user, a product provision processing device for providing products , and a manager terminal device operated by a manager for providing the products are communicably connected to a server,
a product selection means for selecting a product by operating the user terminal device;
a specific product determination means for determining whether the product selected by the product selection means is a specific product;
a product registration means for registering the product selected by the product selection means;
a location information extraction means for extracting location information of a location where the product provision processing device capable of providing the product registered by the product registration means is installed;
a location information transmitting means for transmitting the location information extracted by the location information extracting means to the user terminal device;
a product providing means for providing the product registered by the product registration means to a user;
a person in charge approval means for allowing the person in charge to approve the product to be provided to the user by the person in charge terminal device;
Equipped with
The product registration means
When the specific product determination means determines that the product is not a specific product, the product selected by the product selection means is registered without requiring approval from the responsible person regarding the provision of the product by the responsible person approval means ;
When the specific product determination means determines that the product is a specific product, and the selection of the product is approved by the person in charge approval means, the product selected by the product selection means is registered.
A product provision system characterized by: Further provided is a warning product determination means for determining whether or not a product selected by the product selection means is a warning product from the viewpoint of preventing health damage, even if the product is not the specific product,
The product providing means includes:
If the warning product determination means determines that the product is not a warning product before the product is provided, the product registered by the product registration means is provided to the user;
The product provision system according to claim 1, characterized in that if the warning product determination means determines that the product is a warning product before providing it, the product registered by the product registration means is provided to the user on the condition that the product is approved by the responsible person approval means.